×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Volver a Agenda
Session 3: The IND in Detail - Modules 1, 2, and 5
Session Chair(s)
Elliott Berger, PhD, MS
President
ETB Regualtory Consulting, United States
- IND Item: Form FDA 1571
- IND Item: Table of Contents
- IND Item: Introductory Statement
- IND Item: General Investigation Plan
- IND Item: Investigator’s Brochure
- IND Item: Protocols
¿Tiene una cuenta?